Marked improvement in leptomeningeal carcinomatosis and spinal cord metastases following alectinib treatment of crizotinib-resistant, ALK-positive lung adenocarcinoma

We report a case of 50-year-old Japanese female with anaplastic lymphoma kinase (ALK)-positive, crizotinib-resistant lung adenocarcinoma, whose leptomeningeal carcinomatosis and spinal cord metastases were dramatically improved by the second-generation ALK inhibitor alectinib. Magnetic resonance ima...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int Cancer Conf J
Glavni autori: Kuribayashi, Hidehiko, Abe, Shinji, Kuse, Naoyuki, Kusunoki, Yuji, Narato, Ritsuko, Saito, Hitoshi, Gemma, Akihiko
Format: Artigo
Jezik:Inglês
Izdano: Springer Japan 2015
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6498346/
https://ncbi.nlm.nih.gov/pubmed/31149429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-015-0231-9
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items